Recent research has focused on the reduction of tau pathology for AD treatment, owing to an increased understanding of the molecular mechanisms involved in the formation of neurofibrillary tangles (NFT) which block nerve synapses and cause neuronal cell death. This evidence concerns the gene MAPT and Alzheimer disease.